NYSE:VRS - Verso Stock Price, Forecast & News

Verso trades on the New York Stock Exchange (NYSE) under the ticker symbol "VRS."

Verso Corp (NYSE:VRS) posted its quarterly earnings data on Tuesday, November, 12th. The basic materials company reported $0.85 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.17) by $1.02. The basic materials company earned $616 million during the quarter, compared to the consensus estimate of $629.70 million. View Verso's Earnings History.

Verso is scheduled to release their next quarterly earnings announcement on Friday, March 6th 2020. View Earnings Estimates for Verso.

1 analysts have issued 1 year price objectives for Verso's stock. Their forecasts range from $24.00 to $24.00. On average, they anticipate Verso's share price to reach $24.00 in the next twelve months. This suggests a possible upside of 27.2% from the stock's current price. View Analyst Price Targets for Verso.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Verso in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Verso.

Headlines about VRS stock have been trending somewhat positive this week, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Verso earned a media sentiment score of 1.8 on InfoTrie's scale. They also gave press coverage about the basic materials company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Verso.

Based on aggregate information from My MarketBeat watchlists, some companies that other Verso investors own include Intel (INTC), Micron Technology (MU), Ford Motor (F), Advanced Micro Devices (AMD), Canopy Growth (CGC), NeoPhotonics (NPTN), Pieris Pharmaceuticals (PIRS), Viper Energy Partners (VNOM), Enova International (ENVA) and Cypress Semiconductor (CY).

Verso's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Royce & Associates LP (6.11%), Acadian Asset Management LLC (2.31%), State Street Corp (2.10%), Oaktree Capital Management LP (1.95%), Redwood Capital Management LLC (1.84%) and Charles Schwab Investment Management Inc. (1.64%). Company insiders that own Verso stock include Allen James Campbell and Mudrick Capital Management, L. View Institutional Ownership Trends for Verso.

VRS stock was sold by a variety of institutional investors in the last quarter, including Oaktree Capital Management LP, Redwood Capital Management LLC, AQR Capital Management LLC, Robeco Institutional Asset Management B.V., Donald Smith & CO. Inc., New York State Common Retirement Fund, Acadian Asset Management LLC and Prudential Financial Inc.. View Insider Buying and Selling for Verso.

VRS stock was bought by a variety of institutional investors in the last quarter, including Royce & Associates LP, Voss Capital LLC, Panagora Asset Management Inc., Marshall Wace North America L.P., Mackay Shields LLC, Charles Schwab Investment Management Inc., Marshall Wace LLP and Jacobs Levy Equity Management Inc.. View Insider Buying and Selling for Verso.

Shares of VRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VRS stock can currently be purchased for approximately $18.87.